[go: up one dir, main page]

WO2021127965A1 - Method for recycling voriconazole enantiomer - Google Patents

Method for recycling voriconazole enantiomer Download PDF

Info

Publication number
WO2021127965A1
WO2021127965A1 PCT/CN2019/127798 CN2019127798W WO2021127965A1 WO 2021127965 A1 WO2021127965 A1 WO 2021127965A1 CN 2019127798 W CN2019127798 W CN 2019127798W WO 2021127965 A1 WO2021127965 A1 WO 2021127965A1
Authority
WO
WIPO (PCT)
Prior art keywords
voriconazole
organic solvent
enantiomers
reaction
recovering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2019/127798
Other languages
French (fr)
Chinese (zh)
Inventor
刘杰
董雪林
覃志俊
蔡强
王晴晴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/CN2019/127798 priority Critical patent/WO2021127965A1/en
Priority to CN201980103211.9A priority patent/CN114829354A/en
Publication of WO2021127965A1 publication Critical patent/WO2021127965A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Definitions

  • the invention relates to the field of medicinal chemistry, in particular to a method for recovering voriconazole enantiomers.
  • Voriconazole is a triazole antifungal and a second-generation synthetic derivative of fluconazole. It is the first-line treatment for invasive Aspergillus infection and Candida krusei infection. Its mechanism of action is to inhibit fungal cytochrome P450 (CYP450) end-dependent lanosterol 14 ⁇ demethylation to exert its antifungal effect, which is a crucial step in the synthesis of fungal cell membrane ergosterol. In vitro tests have shown that voriconazole has a broad-spectrum antifungal effect. It has antibacterial effects on all Candida species (including fluconazole-resistant Candida krusei, Candida glabrata and Candida albicans resistant strains).
  • CYP450 fungal cytochrome P450
  • Voriconazole has the advantages of broad antibacterial spectrum and strong antibacterial efficacy, especially for the advantages of good curative effect on invasive Aspergillus infection.
  • Voriconazole (2R, 3S) is a chiral compound with two chiral centers in the structure, with two diastereomers (2R, 3R/2S, 3S) and one enantiomer (2S, 3R) .
  • the physical and chemical properties of diastereoisomers are generally different, and they are easy to separate and remove during the production process.
  • Enantiomers have the same physical and chemical properties as voriconazole in an achiral environment, and are difficult to separate and remove in the production process.
  • the reported voriconazole is generally obtained by resolving the voriconazole racemate (2R, 3S/2S, 3R) with a chiral resolving agent.
  • the recovery of the chiral resolving agent is relatively simple and can generally be used repeatedly.
  • the yield of voriconazole (2R, 3S) obtained after resolution using a resolving agent is about 40%, and the voriconazole enantiomer (2S, 3R) obtained by resolution has two treatment methods, one is to Voriconazole isomers (2S, 3R) are converted to voriconazole, but because the voriconazole isomers (2S, 3R) contain two chiral centers for the conversion of isomers, four isomers 2S, 3R, 2R, 3S, 2R, 3R, and 2S, 3S, after the four isomers obtained are separated and resolved, the conversion efficiency of the obtained voriconazole is low, and the process flow is relatively complicated, which is not suitable for industrial production; the other is The enantiomers of voriconazole are treated directly as waste, which not only causes environmental pollution, but also increases production costs. Therefore, there is an urgent need for a method suitable for industrial processing of voriconazole isomers.
  • the present invention discloses a method for recovering the enantiomers of voriconazole.
  • the method has a simple process route, convenient operation in the treatment process, and the reaction process.
  • the substances used are all commonly used substances in the experiment, which have the advantages of low harm to the human body, reuse of waste, environmental friendliness, and no waste of resources, and the substances obtained by the reaction can again become the starting materials for the preparation of voriconazole.
  • the method for recovering the enantiomers of voriconazole of the present invention includes the following steps: mixing the enantiomers of voriconazole with a reaction solvent containing a basic substance A, heating to temperature I for reaction, and obtaining formula II and formula III after the reaction is completed ,
  • the specific reaction is as follows:
  • the reaction is completed, it is concentrated under reduced pressure, the concentrate is added with organic solvent A and water, the formula III is recovered and separated from the water layer, and the formula II is recovered from the oil layer.
  • the concentrate is added with organic solvent A and water, stirred and dissolved, and then separated, the oil layer is collected, water is continued to be added to the oil layer, the pH value of the solution is adjusted with acidic substances, and the liquid is separated. Collect oil and water layers.
  • the method for recovering the enantiomers of voriconazole of the present invention is to concentrate the collected oil layer, add a separating solvent and stir to dissolve, then cool to temperature II, stir and crystallize and filter with suction to obtain formula II; add organic solvent to the collected water layer B. Adjust the pH value of the solution with the alkaline substance B, separate the liquids, collect the organic solvent layer, and distill the organic solvent under reduced pressure, then heat to temperature III and distill under reduced pressure to obtain formula III.
  • the mass ratio of the voriconazole enantiomers of formula I to the reaction solvent is 1:3 to 1:8, and the voriconazole enantiomers of formula I are basic
  • the mass ratio of substance A is 3:1 ⁇ 7:1.
  • the reaction solvent is one or two of methanol, ethanol, propanol, isopropanol, acetone and n-butanol
  • the basic substance A is a strong base
  • the strong alkaline substance is one or two of lithium hydroxide, sodium hydroxide and potassium hydroxide.
  • the reaction temperature I of the voriconazole enantiomer of formula I and the basic substance A is 60-85° C., and the reaction time is 10-20 hours.
  • the organic solvent A is one or two of toluene, dichloromethane and chloroform
  • the acidic substance is hydrochloric acid, sulfuric acid, nitric acid and acetic acid.
  • the pH of the solution is 1-5.
  • the separation solvent is one or two of acetone, methyl acetate, ethyl acetate, ether and phenol; the temperature II is 0-10°C.
  • the alkaline substance B is one or two of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, lithium hydroxide, sodium hydroxide and potassium hydroxide
  • the organic solvent B is one or two of toluene, dichloromethane and chloroform, and the pH value of the solution is 8-12.
  • the temperature III is 70°C to 90°C, and the pressure is -0.085 to -0.095 MPa.
  • the 2,4-difluoro-2-[1-(1H-1,2,4-triazolyl)]acetophenone (formula II) is recovered The rate is 86%-95%, and the 6-ethyl-5-fluoropyrimidine (formula III) is 85%-95%.
  • the method has the advantages of simple process route, convenient operation in the treatment process, the materials used in the reaction process are all commonly used in the experiment, little harm to the human body, repeated use of waste, environmental friendliness, no waste of resources, etc.
  • the present invention The yields of the obtained products are all above 85%, and some can reach above 90%, and the separation of the products is simple, and the materials obtained by the reaction can be used as starting materials for preparing voriconazole.
  • reagents used in the present invention can be purchased from the market or can be prepared by the method of the prior art or prepared by the method described in the present invention.
  • °C degrees Celsius
  • g grams
  • Mpa megapascals
  • h hours.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Disclosed is a method for recycling a voriconazole enantiomer. The specific steps are as follows: mixing the voriconazole enantiomer with a reaction solvent containing basic substance A; after the reaction ends, concentrating same under reduced pressure; adding organic solvent A and water, stirring and dissolving same, then separating liquid, and collecting an oil layer; continuously adding water, adjusting the pH of the solution with an acidic substance, separating liquid, and concentrating the oil layer; adding a separation solvent, stirring and dissolving same, and then lowering the temperature; and performing crystallization and then subjecting same to suction filtration to obtain formula II; adding organic solvent B to a collected water layer, adjusting the pH value of the solution by using basic substance B; separating liquid, distilling the organic solvent layer under reduced pressure, and then raising the temperature and performing distillation under reduced pressure to obtain formula III. The method has the advantages of a simple process route, convenient operations in the process of processing, little harm to the human body, repeated utilization of waste, being environmentally friendly, not wasting resources, etc.

Description

一种伏立康唑对映异构体的回收方法Method for recovering voriconazole enantiomers 技术领域Technical field

本发明涉及医药化学领域,具体涉及一种伏立康唑对映异构体的回收方法。The invention relates to the field of medicinal chemistry, in particular to a method for recovering voriconazole enantiomers.

背景技术Background technique

伏立康唑(voriconazole)是一个三唑类抗真菌药和氟康唑的一个第二代合成衍生物,是侵袭性曲霉感染和克柔念珠菌感染的一线治疗药物。它的作用机制是通过抑制真菌中细胞色素P450(CYP450)端依赖的羊毛甾醇14α去甲基化发挥其抗真菌作用,这是真菌的细胞膜麦角固醇的合成至关重要的一步。体外试验表明伏立康唑具有广谱抗真菌作用,对所有的念珠菌属物种(包括耐氟康唑的克柔念珠菌、光滑念珠菌和白念珠菌耐药株)具有抗菌作用,对所有检测的曲霉菌属真菌具有杀菌作用,此外,伏立康唑在体外对其他致病性真菌也有杀菌作用,包括对现有抗真菌药敏感性较低的菌属,例如足放线病菌属和镰刀菌属。伏立康唑具有抗菌谱广,抗菌效力强的优点,尤其是对侵袭性曲霉菌浸泡感染疗效好的优点。Voriconazole is a triazole antifungal and a second-generation synthetic derivative of fluconazole. It is the first-line treatment for invasive Aspergillus infection and Candida krusei infection. Its mechanism of action is to inhibit fungal cytochrome P450 (CYP450) end-dependent lanosterol 14α demethylation to exert its antifungal effect, which is a crucial step in the synthesis of fungal cell membrane ergosterol. In vitro tests have shown that voriconazole has a broad-spectrum antifungal effect. It has antibacterial effects on all Candida species (including fluconazole-resistant Candida krusei, Candida glabrata and Candida albicans resistant strains). Fungi of the genus Moulds have bactericidal effects. In addition, voriconazole also has bactericidal effects against other pathogenic fungi in vitro, including those that are less sensitive to existing antifungal drugs, such as Actinomyces and Fusarium. Voriconazole has the advantages of broad antibacterial spectrum and strong antibacterial efficacy, especially for the advantages of good curative effect on invasive Aspergillus infection.

伏立康唑结构式如下:The structural formula of voriconazole is as follows:

Figure PCTCN2019127798-appb-000001
Figure PCTCN2019127798-appb-000001

伏立康唑(2R,3S)为手性化合物,结构中有两个手性中心,具有两个非对映异构体(2R,3R/2S,3S)和一个对映异构体(2S,3R)。其中非对映异构体物理化学性质一般不同,在生产工艺过程中易于分离,除去。对映异构体在非手性环境下与伏立康唑具有相同的物理、化学性质,生产工艺中难以分离除去。Voriconazole (2R, 3S) is a chiral compound with two chiral centers in the structure, with two diastereomers (2R, 3R/2S, 3S) and one enantiomer (2S, 3R) . Among them, the physical and chemical properties of diastereoisomers are generally different, and they are easy to separate and remove during the production process. Enantiomers have the same physical and chemical properties as voriconazole in an achiral environment, and are difficult to separate and remove in the production process.

已报道的伏立康唑一般是将伏立康唑消旋体(2R,3S/2S,3R)采用手性拆分剂进行拆分得到,手性拆分剂的回收比较简单,一般可以反复使用。使用拆分剂进行拆分后得到的伏立康唑(2R,3S)收率大概为40%左右,而拆分得到的伏立康唑对映异构体(2S,3R)有两种处理方法,一种是将伏立康唑异构体(2S,3R)向伏立康唑转化,但由于伏立康唑异构体(2S,3R)中含有两个手性中心翻转进行异构体的转化,能够得到四种异构体2S,3R、2R,3S、2R,3R、和2S,3S,将得到的四种异构体进行分离拆分后,得到的伏立康唑转化效率低,同时工艺流程比较复杂,不适合工业化生产;另一种是将伏立康唑对映异构体是直接当做废弃物处理,这样做不仅造成环境污染,还会增加生产成本。因此,急需一种适合工业化处理伏立康唑异 构体的方法。The reported voriconazole is generally obtained by resolving the voriconazole racemate (2R, 3S/2S, 3R) with a chiral resolving agent. The recovery of the chiral resolving agent is relatively simple and can generally be used repeatedly. The yield of voriconazole (2R, 3S) obtained after resolution using a resolving agent is about 40%, and the voriconazole enantiomer (2S, 3R) obtained by resolution has two treatment methods, one is to Voriconazole isomers (2S, 3R) are converted to voriconazole, but because the voriconazole isomers (2S, 3R) contain two chiral centers for the conversion of isomers, four isomers 2S, 3R, 2R, 3S, 2R, 3R, and 2S, 3S, after the four isomers obtained are separated and resolved, the conversion efficiency of the obtained voriconazole is low, and the process flow is relatively complicated, which is not suitable for industrial production; the other is The enantiomers of voriconazole are treated directly as waste, which not only causes environmental pollution, but also increases production costs. Therefore, there is an urgent need for a method suitable for industrial processing of voriconazole isomers.

发明内容Summary of the invention

为了解决以上两种处理伏立康唑对映异构体的方法存在的问题,本发明公开了一种伏立康唑对映异构体的回收方法,该方法具有工艺路线简单,处理过程中操作方便,反应过程中所用到的物质均是实验中常用物质,对人体危害小,对废弃物重复利用,对环境友好,不浪费资源等优点,而且反应得到的物质可以再次成为制备伏立康唑的起始物料。In order to solve the problems of the above two methods for processing the enantiomers of voriconazole, the present invention discloses a method for recovering the enantiomers of voriconazole. The method has a simple process route, convenient operation in the treatment process, and the reaction process. The substances used are all commonly used substances in the experiment, which have the advantages of low harm to the human body, reuse of waste, environmental friendliness, and no waste of resources, and the substances obtained by the reaction can again become the starting materials for the preparation of voriconazole.

本发明的伏立康唑对映异构体的回收方法,包括以下步骤,将伏立康唑对映异构体与含碱性物质A的反应溶剂混合,加热至温度I反应,反应结束后得到式II和式III,具体反应如下式:The method for recovering the enantiomers of voriconazole of the present invention includes the following steps: mixing the enantiomers of voriconazole with a reaction solvent containing a basic substance A, heating to temperature I for reaction, and obtaining formula II and formula III after the reaction is completed , The specific reaction is as follows:

Figure PCTCN2019127798-appb-000002
Figure PCTCN2019127798-appb-000002

本发明的伏立康唑对映异构体的回收方法,所述反应结束后,减压浓缩,浓缩物加入有机溶剂A和水,水层中回收分离式III,油层中回收式II。In the method for recovering voriconazole enantiomers of the present invention, after the reaction is completed, it is concentrated under reduced pressure, the concentrate is added with organic solvent A and water, the formula III is recovered and separated from the water layer, and the formula II is recovered from the oil layer.

本发明的伏立康唑对映异构体的回收方法,所述浓缩物加入有机溶剂A和水搅拌溶解后分液,收集油层,在油层中继续加水,用酸性物质调节溶液的pH值,分液,收集油层和水层。In the method for recovering voriconazole enantiomers of the present invention, the concentrate is added with organic solvent A and water, stirred and dissolved, and then separated, the oil layer is collected, water is continued to be added to the oil layer, the pH value of the solution is adjusted with acidic substances, and the liquid is separated. Collect oil and water layers.

本发明的伏立康唑对映异构体的回收方法,将收集的油层浓缩,加入分离溶剂搅拌溶解后,降温至温度II,搅拌析晶后抽滤,得到式II;在收集的水层加入有机溶剂B,用碱性物质B调节溶液的pH值,分液,收集有机溶剂层,减压蒸馏去除有机溶剂后,加热至温度III减压蒸馏得到式III。The method for recovering the enantiomers of voriconazole of the present invention is to concentrate the collected oil layer, add a separating solvent and stir to dissolve, then cool to temperature II, stir and crystallize and filter with suction to obtain formula II; add organic solvent to the collected water layer B. Adjust the pH value of the solution with the alkaline substance B, separate the liquids, collect the organic solvent layer, and distill the organic solvent under reduced pressure, then heat to temperature III and distill under reduced pressure to obtain formula III.

本发明的伏立康唑对映异构体的回收方法,所述式I伏立康唑对映异构体与反应溶剂质量比为1:3~1:8,所述式I伏立康唑对映异构体与碱性物质A质量比为3:1~7:1。In the method for recovering voriconazole enantiomers of the present invention, the mass ratio of the voriconazole enantiomers of formula I to the reaction solvent is 1:3 to 1:8, and the voriconazole enantiomers of formula I are basic The mass ratio of substance A is 3:1~7:1.

本发明的伏立康唑对映异构体的回收方法,所述反应溶剂为甲醇、乙醇、丙醇、异丙醇、丙酮和正丁醇中的一种或两种,所述碱性物质A为强碱性物质,所述强碱性物质为氢氧化锂、氢氧化钠和氢氧化钾中的一种或两种。In the method for recovering voriconazole enantiomers of the present invention, the reaction solvent is one or two of methanol, ethanol, propanol, isopropanol, acetone and n-butanol, and the basic substance A is a strong base The strong alkaline substance is one or two of lithium hydroxide, sodium hydroxide and potassium hydroxide.

本发明的伏立康唑对映异构体的回收方法,所述式I伏立康唑对映异构体与碱性物质A的反应的温度I为60~85℃,反应时间为10~20小时。In the method for recovering voriconazole enantiomers of the present invention, the reaction temperature I of the voriconazole enantiomer of formula I and the basic substance A is 60-85° C., and the reaction time is 10-20 hours.

本发明的伏立康唑对映异构体的回收方法,所述有机溶剂A为甲苯、二氯甲烷和三氯甲烷中的一种或两种,所述酸性物质为盐酸、硫酸、硝酸和乙酸中的一种或两种,所述溶液pH值为1~5。In the method for recovering the enantiomers of voriconazole of the present invention, the organic solvent A is one or two of toluene, dichloromethane and chloroform, and the acidic substance is hydrochloric acid, sulfuric acid, nitric acid and acetic acid. One or two, the pH of the solution is 1-5.

本发明的伏立康唑对映异构体的回收方法,所述分离溶剂为丙酮、乙酸甲酯、乙酸乙酯、乙醚和苯酚中的一种或两种;所述温度II为0~10℃。In the method for recovering voriconazole enantiomers of the present invention, the separation solvent is one or two of acetone, methyl acetate, ethyl acetate, ether and phenol; the temperature II is 0-10°C.

本发明的伏立康唑对映异构体的回收方法,所述碱性物质B为碳酸钠、碳酸钾、醋酸钠、醋酸钾、氢氧化锂、氢氧化钠和氢氧化钾中的一种或两种,所述有机溶剂B为甲苯、二氯甲烷和三氯甲烷中的一种或两种,所述溶液pH值为8~12。In the method for recovering voriconazole enantiomers of the present invention, the alkaline substance B is one or two of sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, lithium hydroxide, sodium hydroxide and potassium hydroxide The organic solvent B is one or two of toluene, dichloromethane and chloroform, and the pH value of the solution is 8-12.

本发明的伏立康唑对映异构体的回收方法,所述温度III为70℃~90℃,所述压力为-0.085~-0.095MPa。In the method for recovering voriconazole enantiomers of the present invention, the temperature III is 70°C to 90°C, and the pressure is -0.085 to -0.095 MPa.

本发明的伏立康唑对映异构体的回收方法,所述2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮(式II)的收率为86%~95%,所述6-乙基-5-氟嘧啶(式III)为85%~92%。In the method for recovering the enantiomers of voriconazole of the present invention, the 2,4-difluoro-2-[1-(1H-1,2,4-triazolyl)]acetophenone (formula II) is recovered The rate is 86%-95%, and the 6-ethyl-5-fluoropyrimidine (formula III) is 85%-95%.

该方法具有工艺路线简单,处理过程中操作方便,反应过程中所用到的物质均是实验中常用物质,对人体危害小,对废弃物重复利用,对环境友好,不浪费资源等优点,本发明所得的产物的收率均在85%以上,部分能达到90%以上,且产物分离简单,反应制得物质可作为制备伏立康唑的起始物料。The method has the advantages of simple process route, convenient operation in the treatment process, the materials used in the reaction process are all commonly used in the experiment, little harm to the human body, repeated use of waste, environmental friendliness, no waste of resources, etc. The present invention The yields of the obtained products are all above 85%, and some can reach above 90%, and the separation of the products is simple, and the materials obtained by the reaction can be used as starting materials for preparing voriconazole.

具体实施方式Detailed ways

为了使本领域的技术人员更好地理解本发明的技术方案,下面进一步披露一些非限制实施例对本发明作进一步的详细说明。本发明所使用的试剂均可以从市场上购得或者可以通过现有技术的方法制备或者通过本发明所描述的方法制备而得。In order to enable those skilled in the art to better understand the technical solutions of the present invention, some non-limiting embodiments are further disclosed below to further describe the present invention in detail. The reagents used in the present invention can be purchased from the market or can be prepared by the method of the prior art or prepared by the method described in the present invention.

本发明中,℃表示摄氏度,g表示克,Mpa表示兆帕,h表示小时。In the present invention, °C represents degrees Celsius, g represents grams, Mpa represents megapascals, and h represents hours.

实施例1Example 1

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和氢氧化锂20g,升温65℃反应10h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A三氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A三氯甲烷层,在收集的三氯甲烷层中继续加入200g水,用浓硫酸调节pH至1,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of reaction solvent methanol and 20 g of lithium hydroxide into the reaction flask, and react at 65° C. for 10 hours. After the reaction is completed, the methanol is recovered by concentration under reduced pressure. The concentrate is added with 400g of organic solvent A chloroform and 200g of water after stirring to dissolve, then stand for liquid separation, collect the organic solvent A chloroform layer, and continue to add to the collected chloroform layer 200g water, adjust the pH to 1 with concentrated sulfuric acid, separate the liquids, and collect the oil layer and the water layer.

将最后收集的有机溶剂A三氯甲烷层浓缩至干,加入分离溶剂乙酸甲酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为86.29%。Concentrate the collected organic solvent A chloroform layer to dryness, add 200g of separation solvent methyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4h, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 86.29%.

水层加入200g有机溶剂B三氯甲烷,用醋酸钠溶液调节pH为8,分液,收集有机溶 剂B三氯甲烷层,30℃减压蒸馏去除有机溶剂B三氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为85.33%。Add 200g of organic solvent B chloroform to the water layer, adjust the pH to 8 with sodium acetate solution, separate the layers, collect the organic solvent B chloroform layer, and distill the organic solvent B chloroform under reduced pressure at 30°C, then reduce pressure at 70°C To -0.095Mpa, 6-ethyl-5-fluoropyrimidine (compound of formula III) was obtained by distillation, and the yield was 85.33%.

实施例2Example 2

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂丙酮400g和氢氧化钾20g,升温75℃回流反应20h。反应结束之后减压浓缩回收丙酮,浓缩物加入有机溶剂A甲苯400g和200g水搅拌溶解后,静置分液,收集有机溶剂A甲苯层,在甲苯层中继续加入200g水,用浓硝酸调节pH至5,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of acetone as the reaction solvent, and 20 g of potassium hydroxide into the reaction flask, and react with reflux at 75°C for 20 hours. After the reaction is completed, the acetone is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A toluene and 200g of water and stirred to dissolve, then stand for liquid separation, collect the organic solvent A toluene layer, continue to add 200g of water to the toluene layer, adjust the pH with concentrated nitric acid To 5, separate liquid, collect oil layer and water layer.

将最后收集的有机溶剂A甲苯层浓缩至干,加入分离溶剂乙醚200g搅拌溶解后,降温至8℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为88.27%。The toluene layer of the organic solvent A collected at the end was concentrated to dryness. After adding 200g of the separating solvent ether and stirring to dissolve, the temperature was lowered to 8°C, stirred and crystallized for 4h, and filtered with suction to obtain 2,4-difluoro-2-[1-(1H -1,2,4-triazolyl)] crude acetophenone (compound of formula II), the yield was 88.27%.

水层加入200g有机溶剂B甲苯,用25%的氢氧化钾溶液调节pH为12,分液,收集有机溶剂B甲苯层,30℃减压蒸馏去除有机溶剂B甲苯后,90℃减压至-0.085Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为87.52%。Add 200 g of organic solvent B toluene to the water layer, adjust the pH to 12 with 25% potassium hydroxide solution, separate the layers, collect the organic solvent B toluene layer, distill the organic solvent B toluene off under reduced pressure at 30°C, and then reduce pressure at 90°C to- 0.085Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 87.52%.

实施例3Example 3

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和氢氧化钠20g,升温85℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓盐酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of ethanol as the reaction solvent, and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at 85°C. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated hydrochloric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为93.84%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 93.84%.

水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为10,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为91.37%。Add 200g of organic solvent B dichloromethane to the water layer, adjust the pH to 10 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 80°C 0.09Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 91.37%.

实施例4Example 4

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和碳酸钠20g,升温65℃回流反应10h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至1,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of reaction solvent methanol and 20 g of sodium carbonate into the reaction flask, and reflux at 65° C. for reaction for 10 hours. After the reaction, the methanol was recovered by concentration under reduced pressure. The concentrate was added with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stood still for liquid separation, collected the dichloromethane layer of organic solvent A, and continued to add 200g of water to the dichloromethane layer , Adjust the pH to 1 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解 后,降温至0℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为50.96%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separation solvent ethyl acetate and stir to dissolve, then cool to 0°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II) has a yield of 50.96%.

水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为9,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为43.58%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 9 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 70°C 0.095Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 43.58%.

实施例5Example 5

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和醋酸钠20g,升温80℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomers, 400 g of ethanol as the reaction solvent and 20 g of sodium acetate into the reaction flask, and react with reflux at 80° C. for 15 hours. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为41.78%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 41.78%.

水层加入200g有机溶剂B二氯甲烷,用醋酸钠溶液调节pH为12,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为37.62%。Add 200g of organic solvent B dichloromethane to the water layer, adjust the pH to 12 with sodium acetate solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, reduce pressure at 80°C to -0.09Mpa, and distill 6-ethyl-5-fluoropyrimidine (compound of formula III) was obtained with a yield of 37.62%.

实施例6Example 6

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和氢氧化钠20g,升温30℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of reaction solvent methanol and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at 30°C. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为39.84%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 39.84%.

水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为9,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为33.71%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 9 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 70°C 0.095Mpa, distillation to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 33.71%.

实施例7Example 7

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂甲醇400g和氢氧化钠20g,升温50℃回流反应15h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A二氯甲烷400g 和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomers, 400 g of reaction solvent methanol and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at 50°C. After the reaction is completed, the methanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the organic solvent A dichloromethane layer, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为58.64%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 58.64%.

水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为12,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为51.47%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 12 with 25% sodium hydroxide solution, separate the liquids, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 80°C 0.09Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (the compound of formula III), the yield was 51.47%.

实施例8Example 8

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和氢氧化钠20g,升温20℃回流反应15h。反应结束之后减压浓缩回收甲醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硫酸调节pH至3,分液,收集油层和水层。Add 100 g of the voriconazole enantiomer, 400 g of ethanol as the reaction solvent, and 20 g of sodium hydroxide into the reaction flask, and react with reflux at 20° C. for 15 hours. After the reaction, the methanol was recovered by concentration under reduced pressure. The concentrate was added with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stood still for liquid separation, collected the dichloromethane layer of organic solvent A, and continued to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated sulfuric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为38.71%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (compound of formula II), the yield was 38.71%.

水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为12,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,80℃减压至-0.09Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为33.71%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 12 with 25% sodium hydroxide solution, separate the liquids, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce pressure to-at 80°C 0.09Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (compound of formula III), the yield was 33.71%.

实施例9Example 9

在反应瓶中加入伏立康唑对映异构体100g、反应溶剂乙醇400g和氢氧化钠20g,升温40℃回流反应15h。反应结束之后减压浓缩回收乙醇,浓缩物加入有机溶剂A二氯甲烷400g和200g水搅拌溶解后,静置分液,收集有机溶剂A二氯甲烷层,在二氯甲烷层中继续加入200g水,用浓硝酸调节pH至3,分液,收集油层和水层。Add 100 g of voriconazole enantiomer, 400 g of ethanol as the reaction solvent, and 20 g of sodium hydroxide into the reaction flask, and reflux for 15 hours at a temperature of 40°C. After the reaction is over, the ethanol is recovered by concentration under reduced pressure. The concentrate is mixed with 400g of organic solvent A dichloromethane and 200g of water after stirring to dissolve, then stand for liquid separation, collect the dichloromethane layer of organic solvent A, and continue to add 200g of water to the dichloromethane layer , Adjust the pH to 3 with concentrated nitric acid, separate the liquids, and collect the oil and water layers.

将最后收集的有机溶剂A二氯甲烷层浓缩至干,加入分离溶剂乙酸乙酯200g搅拌溶解后,降温至3℃,搅拌析晶4h,抽滤,得到2,4-二氟-2-[1-(1H-1,2,4-三唑基)]苯乙酮粗品(式II化合物),收率为49.21%。Concentrate the last collected dichloromethane layer of organic solvent A to dryness, add 200 g of the separating solvent ethyl acetate and stir to dissolve, then cool to 3°C, stir and crystallize for 4 hours, and filter with suction to obtain 2,4-difluoro-2-[ The crude product of 1-(1H-1,2,4-triazolyl)]acetophenone (the compound of formula II), the yield was 49.21%.

水层加入200g有机溶剂B二氯甲烷,用25%的氢氧化钠溶液调节pH为10,分液,收集二氯甲烷层,30℃减压蒸馏去除二氯甲烷后,70℃减压至-0.095Mpa,蒸馏得到6-乙基-5-氟嘧啶(式III化合物),收率为43.85%。Add 200 g of organic solvent B dichloromethane to the water layer, adjust the pH to 10 with 25% sodium hydroxide solution, separate the layers, collect the dichloromethane layer, distill the dichloromethane under reduced pressure at 30°C, and then reduce the pressure to-at 70°C 0.095Mpa, distilled to obtain 6-ethyl-5-fluoropyrimidine (the compound of formula III), the yield was 43.85%.

Claims (10)

一种伏立康唑对映异构体的回收方法,其特征在于,包括以下步骤,将伏立康唑对映异构体与含碱性物质A的反应溶剂混合,加热至温度I反应,反应结束后得到式II和式III,具体反应如下式:A method for recovering the enantiomers of voriconazole, which is characterized in that it comprises the following steps: mixing the enantiomers of voriconazole with a reaction solvent containing a basic substance A, heating to temperature I for reaction, and obtaining formula II after the reaction is completed And formula III, the specific reaction is as follows:
Figure PCTCN2019127798-appb-100001
Figure PCTCN2019127798-appb-100001
根据权利要求1所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述反应结束后,减压浓缩,浓缩物加入有机溶剂A和水,水层中回收分离式III,油层中回收式II。The method for recovering the enantiomers of voriconazole according to claim 1, characterized in that, after the reaction is completed, it is concentrated under reduced pressure, the concentrate is added to the organic solvent A and water, and the aqueous layer is recovered and separated by formula III, Formula II is recovered in the oil layer. 根据权利要求2所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述浓缩物加入有机溶剂A和水搅拌溶解后分液,收集油层,在油层中继续加水,用酸性物质调节溶液的pH值,分液,收集油层和水层。The method for recovering the enantiomers of voriconazole according to claim 2, characterized in that the concentrate is added with organic solvent A and water, stirred and dissolved, and then separated, the oil layer is collected, and water is continuously added to the oil layer. The substance adjusts the pH value of the solution, separates the liquid, and collects the oil and water layers. 根据权利要求3所述的一种伏立康唑对映异构体的回收方法,其特征在于,将收集的油层浓缩,加入分离溶剂搅拌溶解后,降温至温度II,搅拌析晶后抽滤,得到式II;在收集的水层加入有机溶剂B,用碱性物质B调节溶液的pH值,分液,收集有机溶剂层,减压蒸馏去除有机溶剂后,加热至温度III减压蒸馏得到式III。The method for recovering the enantiomers of voriconazole according to claim 3, characterized in that the collected oil layer is concentrated, a separating solvent is added and stirred to dissolve, the temperature is lowered to temperature II, the crystallization is stirred and then suction filtered to obtain the formula II; Add organic solvent B to the collected water layer, adjust the pH value of the solution with alkaline substance B, separate liquids, collect the organic solvent layer, distill under reduced pressure to remove the organic solvent, heat to temperature III and distill under reduced pressure to obtain formula III. 根据权利要求4所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述式I伏立康唑对映异构体与反应溶剂质量比为1:3~1:8,所述式I伏立康唑对映异构体与碱性物质A质量比为3:1~7:1;或者所述式I伏立康唑对映异构体与碱性物质A的反应的温度I为60~85℃,反应时间为10~20小时。The method for recovering voriconazole enantiomers according to claim 4, wherein the mass ratio of the voriconazole enantiomers of formula I to the reaction solvent is 1:3 to 1:8, and the formula I. The mass ratio of the enantiomer of voriconazole and the basic substance A is 3:1-7:1; or the reaction temperature I of the voriconazole enantiomer of formula I and the basic substance A is 60-85°C, The reaction time is 10-20 hours. 根据权利要求5所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述反应溶剂为甲醇、乙醇、丙醇、异丙醇、丙酮和正丁醇中的一种或两种,所述碱性物质A为强碱性物质,所述强碱性物质为氢氧化锂、氢氧化钠和氢氧化钾中的一种或两种。The method for recovering voriconazole enantiomers according to claim 5, wherein the reaction solvent is one or two of methanol, ethanol, propanol, isopropanol, acetone and n-butanol The alkaline substance A is a strong alkaline substance, and the strong alkaline substance is one or two of lithium hydroxide, sodium hydroxide and potassium hydroxide. 根据权利要求1~6任一项所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述有机溶剂A为甲苯、二氯甲烷和三氯甲烷中的一种或两种,所述酸性物质为盐酸、硫酸、硝酸和乙酸中的一种或两种,所述溶液pH值为1~5。The method for recovering voriconazole enantiomers according to any one of claims 1 to 6, wherein the organic solvent A is one or two of toluene, dichloromethane and chloroform The acidic substance is one or two of hydrochloric acid, sulfuric acid, nitric acid and acetic acid, and the pH value of the solution is 1-5. 根据权利要求1~6任一项所述的一种伏立康唑对映异构体的回收方法,其特征在于,或者所述分离溶剂为丙酮、乙酸甲酯、乙酸乙酯、乙醚和苯酚中的一种或两种,所述温度 II为0~10℃。The method for recovering voriconazole enantiomers according to any one of claims 1 to 6, characterized in that, or the separation solvent is one of acetone, methyl acetate, ethyl acetate, ethyl ether and phenol One or two kinds, the temperature II is 0-10°C. 根据权利要求1~6任一项所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述碱性物质B为碳酸钠、碳酸钾、醋酸钠、醋酸钾、氢氧化锂、氢氧化钠和氢氧化钾中的一种或两种,所述有机溶剂B为甲苯、二氯甲烷和三氯甲烷中的一种或两种,所述溶液pH值为8~12。The method for recovering voriconazole enantiomers according to any one of claims 1 to 6, wherein the alkaline substance B is sodium carbonate, potassium carbonate, sodium acetate, potassium acetate, lithium hydroxide , One or two of sodium hydroxide and potassium hydroxide, the organic solvent B is one or two of toluene, dichloromethane and chloroform, and the pH of the solution is 8-12. 根据权利要求1~6任一项所述的一种伏立康唑对映异构体的回收方法,其特征在于,所述温度III为70℃~90℃,所述压力为-0.085~-0.095MPa。The method for recovering voriconazole enantiomers according to any one of claims 1 to 6, wherein the temperature III is 70°C to 90°C, and the pressure is -0.085 to -0.095 MPa.
PCT/CN2019/127798 2019-12-24 2019-12-24 Method for recycling voriconazole enantiomer Ceased WO2021127965A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2019/127798 WO2021127965A1 (en) 2019-12-24 2019-12-24 Method for recycling voriconazole enantiomer
CN201980103211.9A CN114829354A (en) 2019-12-24 2019-12-24 Recovery method of voriconazole enantiomer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/127798 WO2021127965A1 (en) 2019-12-24 2019-12-24 Method for recycling voriconazole enantiomer

Publications (1)

Publication Number Publication Date
WO2021127965A1 true WO2021127965A1 (en) 2021-07-01

Family

ID=76573416

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/127798 Ceased WO2021127965A1 (en) 2019-12-24 2019-12-24 Method for recycling voriconazole enantiomer

Country Status (2)

Country Link
CN (1) CN114829354A (en)
WO (1) WO2021127965A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113788819A (en) * 2021-08-26 2021-12-14 湖南复瑞生物医药技术有限责任公司 Preparation method of voriconazole

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011096697A2 (en) * 2010-02-04 2011-08-11 Dongkook Pharmaceutical Co., Ltd. Process for preparing voriconazole by using new intermediates
CN106117186A (en) * 2016-06-12 2016-11-16 重庆莱美隆宇药业有限公司 A kind of preparation method of voriconazole and its intermediate
CN107827876A (en) * 2017-10-27 2018-03-23 江苏理工学院 A kind of preparation method of voriconazole raceme
CN109705102A (en) * 2019-02-19 2019-05-03 浙江华海立诚药业有限公司 The preparation method of voriconazole and its intermediate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011096697A2 (en) * 2010-02-04 2011-08-11 Dongkook Pharmaceutical Co., Ltd. Process for preparing voriconazole by using new intermediates
CN106117186A (en) * 2016-06-12 2016-11-16 重庆莱美隆宇药业有限公司 A kind of preparation method of voriconazole and its intermediate
CN107827876A (en) * 2017-10-27 2018-03-23 江苏理工学院 A kind of preparation method of voriconazole raceme
CN109705102A (en) * 2019-02-19 2019-05-03 浙江华海立诚药业有限公司 The preparation method of voriconazole and its intermediate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DUAN XIYU, LIU XIAO-ZHOU;LI LIN;LIU JIA-XIN;YU ZHI-GUO;ZHAO YUN-LI: "Determination of Related Substances in Voriconazole Freeze-Dried Ophthalmic Preparation by HPLC", SHENYANG YAOKE DAXUE XUEBAO - JOURNAL OF SHENYANG PHARMACEUTICAL UNIVERSITY., CHINESE ELECTRONIC PERIODICAL SERVICES, LIAONING, CN, vol. 33, no. 12, 1 December 2016 (2016-12-01), LIAONING, CN, pages 958 - 964, XP055827321, ISSN: 1006-2858, DOI: 10.14066 /j.cnki.cn21-1349 /r.2016.12.008 *
SERVAIS ANNE-CATHERINE; MOLDOVAN RADU; FARCAS ELENA; CROMMEN JACQUES; ROLAND ISABELLE; FILLET MARIANNE: "Development and validation of a liquid chromatographic method for the stability study of a pharmaceutical formulation containing voriconazole using cellulose tris(4-chloro-3-methylphenylcarbamate) as chiral selector and polar organic mobile phases", JOURNAL OF CHROMATOGRAPHY A, ELSEVIER, AMSTERDAM, NL, vol. 1363, 1 July 2014 (2014-07-01), AMSTERDAM, NL, pages 178 - 182, XP029063808, ISSN: 0021-9673, DOI: 10.1016/j.chroma.2014.06.082 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113788819A (en) * 2021-08-26 2021-12-14 湖南复瑞生物医药技术有限责任公司 Preparation method of voriconazole

Also Published As

Publication number Publication date
CN114829354A (en) 2022-07-29

Similar Documents

Publication Publication Date Title
JP2018502909A5 (en)
EP3395813B1 (en) Voriconazole intermediate and voriconazole synthesis method
CN105348172B (en) (S) preparation method of the preparation of the mesyl ethamine of 1 (ethyoxyl of 4 methoxyl group 3) phenyl 2 and Apremilast
US12258330B2 (en) Method for preparing voriconazole and intermediate thereof
US9469593B2 (en) Process for preparing cinacalcet hydrochloride
CN113880744B (en) A chiral separation method for Brivaracetam
CN101260092B (en) Method for preparing cinepazide maleate
CN107445921B (en) A kind of preparation method, product and application of product of high-purity eugenol epoxy
WO2021127965A1 (en) Method for recycling voriconazole enantiomer
CN103044468B (en) Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid
CN100379736C (en) The preparation method of entecavir
CN116332774A (en) A kind of preparation method of metaraminol tartrate with high chiral purity
EP3201171A1 (en) Method of preparing intermediate of salmeterol
CN104961787B (en) Synthetic method of cordycepin
JP2005517000A (en) Process for producing β-cryptoxanthin and α-cryptoxanthin from commercially available lutein
EP3511326A1 (en) Method for preparing voriconazole l-camphorsulphonate and voriconazole
CN110776475A (en) A kind of synthetic method of oxadiazon
CN119930447A (en) A preparation method of meta-hydroxylamine bitartrate
WO2007080470A2 (en) A method for the purification of levetiracetam
CN110683992B (en) Method for synthesizing econazole nitrate by one-pot method
CN104876812B (en) Process for preparing sertraline hydrochloride intermediates and impurities
US20120253051A1 (en) Process for the preparation of ropinirole and salts thereof
CN109293587B (en) Preparation method of clofazimine and intermediate thereof
CN112300150B (en) Preparation method of milpitant and intermediate thereof
CN113956239A (en) Azelastine hydrochloride, and preparation method and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19957875

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19957875

Country of ref document: EP

Kind code of ref document: A1